Surgery Partners appoints Teresa DeLuca to board of directors
In addition to serving on the Board of Directors, Dr. DeLuca will serve on the Company’s Audit Committee.
Dr. DeLuca is an Assistant Clinical professor of psychiatry at the Icahn School of Medicine at Mount Sinai in New York City and serves on the editorial board of the American Health & Drug Benefit Journal.
She was previously the Chief Medical Officer of Magellan Pharmacy Solutions at Magellan Health, SVP of Pharmacy Health Solutions at Humana, VP of Clinical Sales Solutions & National Medical Director at Walgreen Co., and VP of Personalized Medicine as well as VP of Medical Policy & Clinical Quality at Medco.
Prior to taking on these executive leadership roles, Dr. DeLuca was a Senior Director of Global Product Development Services at PRA International and a Senior Medical Scientist at GlaxoSmithKline.
Dr. DeLuca received her M.B.A. from Drexel University and her residency (M.D.) from Jefferson Medical College of Thomas Jefferson University. ■
LATEST MOVES FROM Tennessee
- Bridgestone Americas appoints Stefano Mezzabotta as CIO
- Bridgestone Americas names new president of BATO for U.S. & Canada
- Surgery Partners appoints Clifford Adlerz as interim CEO
- Hankook Tire America appoints two managers
- Fred's appoints Jason Jenne as CFO
More inside POST